# Pharmacokinetics and Safety of Rupatadine in Participants With Hepatic Impairment Compared to Control Participants.

> **NCT06736340** · PHASE1 · COMPLETED · sponsor: **Noucor Health S.A.** · enrollment: 26 (actual)

## Conditions studied

- Hepatic Impairment

## Interventions

- **DRUG:** Rupatadine

## Key facts

- **NCT ID:** NCT06736340
- **Lead sponsor:** Noucor Health S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-17
- **Primary completion:** 2025-04-09
- **Final completion:** 2025-04-09
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2025-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06736340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06736340, "Pharmacokinetics and Safety of Rupatadine in Participants With Hepatic Impairment Compared to Control Participants.". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT06736340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*